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Low-dose/high-concentration localized botulinum toxin A improves upper limb 
movement and function in children with hemiplegic cerebral palsy 
Abstract 
The objective was to determine the effects of low-dose, highconcentration, dual localized botulinum toxin 
A (BTX-A) injections on upper limb movement quality and function. Study design was an evaluator-
blinded, randomized, controlled trial. Forty-two children (31 males, 11 females; range 2–8y, mean 4y [SD 
1.6]) with hemiplegic cerebral palsy (Gross Motor Function Classification System level I)participated. All 
received occupational therapy. The treatment group (n=21) received one injection series (mean muscles 
injected 6 [SD 1.05]; total dose 82–220 units, mean 139 [SD 37.48]; dilution 100 units/0.5ml). Primary 
outcome of Quality of Upper Extremity Skills Test (QUEST) at 6 months was not significant (p=0.318). 
Secondary outcomes were average treatment effects at 1, 3, and 6 months, which favoured the treatment 
group: QUEST (p<0.001); Canadian Occupational Performance Measure (performance, p=0.002; 
satisfaction p=0.007); parent Goal Attainment Scaling (GAS; p=0.001), therapist GAS (p<0.001); Pediatric 
Evaluation of Disability Inventory (PEDI) functional skills (p=0.030); Ashworth (p<0.001). PEDI caregiver 
assistance was not significant (p=0.140). Therapy alone is effective, but at 1 and 3 months movement 
quality is better where BTX-A is also used. Moreover, function is better at 1, 3, and 6 months, suggesting 
BTX-A enhances therapy outcomes beyond the pharmacological effect. One- and 3-month Ashworth and 
QUEST scores suggest precise needle placement accuracy. 
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